Foghorn Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FHTX and other ETFs, options, and stocks.About FHTX
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology.
CEOAdrian Gottschalk
CEOAdrian Gottschalk
Employees112
Employees112
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2015
Founded2015
Employees112
Employees112
FHTX Key Statistics
Market cap265.23M
Market cap265.23M
Price-Earnings ratio-3.95
Price-Earnings ratio-3.95
Dividend yield—
Dividend yield—
Average volume222.80K
Average volume222.80K
High today$4.75
High today$4.75
Low today$4.12
Low today$4.12
Open price$4.26
Open price$4.26
Volume120.98K
Volume120.98K
52 Week high$8.79
52 Week high$8.79
52 Week low$2.94
52 Week low$2.94
Stock Snapshot
As of today, Foghorn Therapeutics(FHTX) shares are valued at $4.69. The company's market cap stands at 265.23M, with a P/E ratio of -3.95.
On 2025-11-16, Foghorn Therapeutics(FHTX) stock traded between a low of $4.12 and a high of $4.75. Shares are currently priced at $4.69, which is +13.8% above the low and -1.3% below the high.
Foghorn Therapeutics(FHTX) shares are trading with a volume of 120.98K, against a daily average of 222.8K.
In the last year, Foghorn Therapeutics(FHTX) shares hit a 52-week high of $8.79 and a 52-week low of $2.94.
In the last year, Foghorn Therapeutics(FHTX) shares hit a 52-week high of $8.79 and a 52-week low of $2.94.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own FHTX. This list is generated using Robinhood data, and it’s not a recommendation.